Error: Could not add to watchlist. X

Ardea Biosciences Inc

+ Watchlist
RDEA:US
Acquired
RDEA:US was acquired by AZN:LN
USD
Volume
0
Current P/E Ratio (TTM)
-
Earnings per Share (USD) (TTM)
-3.92
Market Cap (USD)
-
Shares Outstanding (m)
36.861
Price/Sales (TTM)
-
Dividend Indicated Gross Yield
-
Sector
Health Care
Industry
Biotech & Pharma
Sub-Industry
Biotech

Related Videos

There are currently no related videos for this ticker. Please check back later.
Profile
Ardea Biosciences, Inc. operates as a biotechnology company. The Company develops, manufactures, and distributes small-molecule therapeutics for the treatment of serious diseases. Ardea Biosciences offers products for the management of chronic hyperuricemia in gout patients to healthcare providers, clinics, researchers, and facilities throughout the United States.
ADDRESS
4939 Directors Place
San Diego, CA 92121
United States
PHONE
1-858-652-6500
  • James Mackay
    President/COO
  • Colin E Rowlings
    Senior VP:Pharmaceutical Sciences
  • Kimberly J Manhard
    Senior VP:Regulatory Affairs
  • Chris Storgard
    VP:Clinical Research & Dev
  • Scott Baumgartner
    VP:Clinical Research & Dev
Show More